Valuation: AcouSort AB

Market Cap 75.98M 7.84M 6.87M 6.35M 5.84M 11.03M 756M 11.2M 29.78M 370M 29.45M 28.81M 1.27B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 75.98M 7.84M 6.87M 6.35M 5.84M 11.03M 756M 11.2M 29.78M 370M 29.45M 28.81M 1.27B EV / Sales 2026 *
7.17x
EV / Sales 2027 * 5.13x
Free-Float
59.52%
Yield 2026 *
-
Yield 2027 * -
1 day-1.67%
1 week-3.55%
Current month-6.37%
1 month-12.41%
3 months+15.74%
6 months+38.98%
Current year+24.73%
1 week 3.13
Extreme 3.13
3.85
1 month 3.13
Extreme 3.13
4.18
Current year 2.03
Extreme 2.03
5.16
1 year 2.03
Extreme 2.03
5.16
3 years 2.03
Extreme 2.03
28.6
5 years 2.03
Extreme 2.03
32.95
10 years 2.03
Extreme 2.03
32.95
Manager TitleAgeSince
Chief Executive Officer 68 2013-12-31
Director of Finance/CFO 65 2015-12-31
Director TitleAgeSince
Director/Board Member 64 2011-12-31
Chairman 65 2010-12-31
Director/Board Member - 2021-11-30
Change 5-day change 1-year change 3-year change Capi.($)
-1.67%-3.55%+12.78%-75.90% 7.84M
-1.19%-4.09%-0.53%+13.79% 48.71B
-3.10%-1.94%+370.99%+572.60% 38.35B
-0.46%+2.18%+5.44%+61.01% 34.53B
-1.14%-1.76%+26.94%-9.93% 34.03B
-1.82%-1.43%+0.52%+31.85% 26.77B
-3.54%-5.08% - - 15.64B
-1.82%-0.43%+69.28%+113.82% 15.08B
-1.69%+1.30%+13.51%+14.40% 14.18B
-2.25%+0.05%+15.77%-32.83% 12.73B
Average -1.86%-1.71%+57.19%+76.53% 24B
Weighted average by Cap. -1.72%-1.44%+74.68%+119.24%

Financials

2026 *2027 *
Net sales 10.6M 1.09M 959K 886K 815K 1.54M 106M 1.56M 4.16M 51.63M 4.11M 4.02M 178M 14.8M 1.53M 1.34M 1.24M 1.14M 2.15M 147M 2.18M 5.8M 72.08M 5.74M 5.61M 248M
Net income - -
Net Debt - -
Logo AcouSort AB
Acousort AB is a Sweden-based company engaged in the medical technology. The Company develops, produces and sells standalone laboratory products and integrated original equipment manufacturer (OEM) solutions where ultrasound is used to separate, wash and enrich cells, exosomes and other biological particles for research and diagnostics. Its product portfolio includes AcouWash and AcouTrap that are targeting separation, washing and enrichment applications within cell, bacteria and extracellular vesicle research. In addition, the Company develops proprietary bioanalytical and clinical applications based on acoustophoresis, and offers custom-developed acoustophoresis applications.
Employees
11
Date Price Change Volume
26-07-21 SEK 3.530 -1.67% 2,677
26-07-20 SEK 3.590 +6.21% 5,719
26-07-17 SEK 3.380 -6.63% 23,675
26-07-16 SEK 3.620 -0.28% 22,083
26-07-15 SEK 3.630 -0.82% 5,645

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ACOU Stock